Work

Supplementary Figure 1 from Mutationally Activated PIK3CAH1047R Cooperates with BRAFV600E to Promote Lung Cancer Progression

Year: 2023

Type: supplementary-materials

Abstract: PDF file, 106K, Pharmacological inhibition of AKT does not inhibit BRAFV600E-initiated lung tumorigenesis.

DOI: 10.1158/0008-5472.22397967

Authors: Christy L. Trejo, Shon Green, Victoria Marsh, Eric A. Collisson, Gioia Iezza, Wayne A. Phillips, Martin McMahon

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4361240119

Cites:

Cited by:

Related to: 10